Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.36 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9676287 | 0.91 | CYP3A4 (0.39) | CYP3A4NPSR1HDAC3HDAC4HDAC1 | |
| SCHEMBL8773347 | 0.91 | CYP3A4 (0.39) | CYP3A4LMNAGAAALDH1A1OPRD1 | |
| SCHEMBL20599288 | 0.90 | CYP3A4 (0.42) | CYP3A4NPSR1HDAC3HDAC4HDAC1 | |
| SCHEMBL27797024 | 0.89 | CYP3A4 (0.38) | CYP3A4NPSR1HDAC3HDAC4HDAC1 | |
| SCHEMBL2871678 | 0.87 | CYP3A4 (0.37) | CYP3A4NPSR1HDAC3HDAC4HDAC1 | |
| SCHEMBL27797042 | 0.85 | CYP3A4 (0.35) | CYP3A4NPSR1HDAC3HDAC4HDAC1 | |
| SCHEMBL7770110 | 0.85 | CYP3A4 (0.35) | CYP3A4NPSR1HDAC3HDAC4HDAC1 | |
| SCHEMBL4191136 | 0.84 | CYP3A4 (0.38) | CYP3A4NPSR1HDAC3HDAC4HDAC1 | |
| SCHEMBL4543299 | 0.84 | CYP3A4 (0.38) | CYP3A4NPSR1HDAC3HDAC4HDAC1 | |
| SCHEMBL27539864 | 0.84 | CYP3A4 (0.38) | CYP3A4NPSR1HDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 881 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12551434-B2 | Zwitterionic polymer particle compositions and related methods | WAYNE STATE UNIVERSITY (US) | 2026-02-17 | — | — | US | claimed |
| EP-3766867-B1 | METHOD FOR RECOVERING AMIDE-BASED COMPOUND | LG CHEMICAL LTD (KR) | 2023-11-08 | — | — | EP | claimed |
| CN-112074502-B | Method and apparatus for recovering amide-based compounds | 株式会社LG化学 | 2023-11-03 | — | — | CN | claimed |
| CN-112041374-B | Separation and recovery method of polyarylene sulfide | 株式会社LG化学 | 2023-09-26 | — | — | CN | claimed |
| US-20230225969-A1 | ZWITTERIONIC POLYMER PARTICLE COMPOSITIONS AND RELATED METHODS | WAYNE STATE UNIVERSITY | 2023-07-20 | — | — | US | claimed |
| US-11597800-B2 | Separation and recovery method of polyarlene sulfide | LG CHEM, LTD. (KR) | 2023-03-07 | — | — | US | claimed |
| CN-111630093-B | Process for recovering amide-based compounds | 株式会社LG化学 | 2022-08-12 | — | — | CN | claimed |
| US-11220441-B2 | Process for recovering amide compounds | LG CHEM, LTD. (KR) | 2022-01-11 | — | — | US | claimed |
| WO-2021236922-A1 | ZWITTERIONIC POLYMER PARTICLE COMPOSITIONS AND RELATED METHODS | WAYNE STATE UNIVERSITY (US) | 2021-11-25 | — | — | WO | claimed |
| US-20210238354-A1 | SEPARATION AND RECOVERY METHOD OF POLYARLENE SULFIDE | LG CHEM, LTD. (KR) | 2021-08-05 | — | — | US | claimed |
| EP-0198345-B1 | PROCESS FOR PRODUCING 1,3-DIALKYL-2-IMIDAZOLIDINONE | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-08-01 | — | — | EP | claimed |
| US-4731453-A | Process for producing 1, 3-dialkyl-2-imidazolidinone | MITSUI TOATSU CHEMICALS, INC. (JP) | 1988-03-15 | — | — | US | claimed |
| EP-0198345-A1 | Process for producing 1,3-dialkyl-2-imidazolidinone | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1986-10-22 | — | — | EP | claimed |
| US-4440919-A | CROSSLINKED WITH RESONANCE FREE DI(ALKENE TERTIARY AMINE) CYCLIC COMPOUNDS | BAUSCH & LOMB INCORPORATED (US) | 1984-04-03 | — | — | US | claimed |
| US-4436887-A | CONTACT LENSES, OXYGEN PERMEABILITY | BAUSCH & LOMB INCORPORATED (US) | 1984-03-13 | — | — | US | claimed |
| US-4425162-A | Method for providing a color image by ink-jet printing | FUJI PHOTO FILM CO., LTD. (JP) | 1984-01-10 | — | — | US | claimed |
| US-4388115-A | WATER SOLUBLE YELLOW AZO DYE WITH WETTING AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1983-06-14 | — | — | US | claimed |
| EP-0079720-A2 | Low n-vinyl lactam content-based biomedical devices and process for preparation thereof | BAUSCH & LOMB INCORPORATED (US) | 1983-05-25 | — | — | EP | claimed |
| EP-0079721-A2 | N-vinyl lactam-based biomedical devices and process for preparation thereof | BAUSCH & LOMB INCORPORATED (US) | 1983-05-25 | — | — | EP | claimed |
| US-4302547-A | BY REACTING SYNTHESIS GAS IN THE PRESENCE OF A RHODIUM CARBONYL COMPLEX CATALYST | UNION CARBIDE CORPORATION (US) | 1981-11-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230225969-A1 | ZWITTERIONIC POLYMER PARTICLE COMPOSITIONS AND RELATED METHODS | IAPP, IGFBP6, SI | CYP3A4 4582/4885NPSR1 1636/4885HDAC3 4333/4885 |
| US-12551434-B2 | Zwitterionic polymer particle compositions and related methods | IAPP, GIPR, INSR | CYP3A4 4563/4885NPSR1 1948/4885HDAC3 3308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.